February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Deridre Kelly: Anti–PD-L1 and TKI in anaplastic thyroid cancer
Nov 2, 2024, 19:05

Deridre Kelly: Anti–PD-L1 and TKI in anaplastic thyroid cancer

Deridre Kelly, Medical Oncologist at Mater Misericordiae University Hospital, shared a post on X:

“Immuno Oncology: Anti–PD-L1 and TKI in anaplastic thyroid cancer.

Median OS: 19 mosBRAF V600E-mutated patients: 43 mos (50% ORR)
Longest OS in ATC history!

Targeted and immunotherapy synergy outcomes.”

Deridre Kelly: Anti–PD-L1 and TKI in anaplastic thyroid cancer